By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
CryptoCommunityCryptoCommunity
  • Home
  • General
  • Blockchain
  • Crypto
  • DeFi
  • Metaverse
  • NFT
Search
  • BTC
  • ETH
  • USDT
  • USDC
  • BNB
  • BUSD
  • ADA
  • XRP
  • SOL
  • DOGE
  • DOT
  • MATIC
Reading: Moderna sues Pfizer, BioNTech over alleged mRNA patent infringement – TechCrunch
Share
Aa
CryptoCommunityCryptoCommunity
Aa
  • Home
  • General
  • Blockchain
  • Crypto
  • DeFi
  • Metaverse
  • NFT
Search
  • Home
  • General
  • Blockchain
  • Crypto
  • DeFi
  • Metaverse
  • NFT
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
CryptoCommunity > Blog > General > Moderna sues Pfizer, BioNTech over alleged mRNA patent infringement – TechCrunch
General

Moderna sues Pfizer, BioNTech over alleged mRNA patent infringement – TechCrunch

admin Published August 27, 2022
Last updated: 2022/08/27 at 12:11 AM
Share
SHARE

[ad_1]

Moderna filed a lawsuit against Pfizer and BioNTech claiming the biopharmaceutical companies infringed on Moderna’s patents related to mRNA technology in develop of their COVID-19 vaccine.

The lawsuit, to be filed in the U.S. District Court in Massachusetts and Regional Court of Düsseldorf in Germany, alleges Pfizer-BioNTech’s vaccine Comirnaty infringes on Moderna’s patent filed between 2010 and 2016.

“We believe that Pfizer and BioNTech unlawfully copied Moderna’s inventions, and they have continued to use them without permission,” said Moderna chief legal officer Shannon Thyme Klinger in the company’s press release.

A Pfizer spokesperson told TechCrunch they are stunned by the allegations because “the Pfizer/BioNTech COVID-19 vaccine was based on BioNTech’s proprietary mRNA technology and developed by both BioNTech and Pfizer.”

TechCrunch reached out to BioNTech for an individual statement but did not receive an immediate response.

Moderna is accusing the companies of copying two features they claim are “critical to the success of the mRNA vaccines.” One of the features includes a chemical modification to help avoid undesirable immune responses to mRNA, and the other is related to the encoding of the spike protein in a lipid molecule.

The company is currently seeking monetary damages, but isn’t looking for an injunction to force Pfizer and BioNTech’s vaccine off the market.

“This foundational platform, which we began building in 2010, along with our patented work on coronaviruses in 2015 and 2016, enabled us to produce a safe and highly effective COVID-19 vaccine in record time after the pandemic struck,” said Moderna Chief Executive Officer Stéphane Bancel in the release. “As we work to combat health challenges moving forward, Moderna is using our mRNA technology platform to develop medicines that could treat and prevent infectious diseases like influenza and HIV, as well as autoimmune and cardiovascular diseases and rare forms of cancer.”

Moderna announced they began development on mRNA vaccines targeting the seasonal flu HIV and Nipah virus back in 2021.

According to the Centers for Disease Control and Prevention, over 360 million doses of Pfizer-BioNTech’s COVID-19 vaccine have been administered in the country. Moderna has had close to 230 million doses administered.

[ad_2]

You Might Also Like

Revyze is building the TikTok of educational videos

YouTube ends the test asking users to get a premium subscription to watch 4K videos

Who is going to buy Cadillac’s $300,000 hand-built EV?

Don’t let today’s software rally improve your mood

Daily Crunch: Kanye West reaches agreement to acquire social media platform Parler

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
[mc4wp_form]
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
admin August 27, 2022
Share this Article
Facebook TwitterEmail Print
Share
Previous Article New White House directive will require free access to studies funded by tax dollars – TechCrunch
Next Article Bitcoin MVRV Ratio Is Back Below 1 As Average Holder Slips Into Loss

Latest News

earn bitcoins fast
How to earn bitcoins fast
crypto
Cryptocurrency is a Scam or Not
How to Tell If a Cryptocurrency is a Scam or Not
crypto
Losing In Cryptocurrency Trading
Tips to Avoid Losing In Cryptocurrency Trading
crypto
Sell Products Online with Bitcoins
How to Sell Products Online with Bitcoins – The Ultimate Guide
crypto

You Might also Like

Revyze is building the TikTok of educational videos

6 Min Read

YouTube ends the test asking users to get a premium subscription to watch 4K videos

2 Min Read

Who is going to buy Cadillac’s $300,000 hand-built EV?

4 Min Read

Don’t let today’s software rally improve your mood

1 Min Read

Crypto Community

  • Home
  • Crypto Calculator
  • Blog
  • Contact Us
  • Privacy Policy
  • Disclaimer
  • Terms and Conditions

Real time Cryptocurrency

  • Crypto Prices
  • Dogecoin price
  • Shibainu coin price
  • Bitcoin Price
  • Cardano Price
  • Litecoins Price

Cryptocurrency Price USD

  • Bitcoin price USD
  • Ethereum price USD
  • Tether price USD
  • BNB Price USD
  • Cardano Price USD
  • Solana Price USD
  • Peps coin Price USD
  • floki inu Price USD
  • SIA coin Price USD
CryptoCommunityCryptoCommunity
Follow US

© 2022 Cryptos Community All Rights Reserved. All logos and images used on this website are registered trademarks of their respective companies. All Rights Reserved. Cryptos Community is not liable for inaccuracies, errors, or omissions found herein. For the removal of copyrighted images, trademarks, or other issues, Contact Us. 


Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?